FGFR4 and neoplasm: In breast cancer, wild type FGFR4 has been proposed to be an important tumor suppressor via the regulation of genes controlling invasion like matrix metalloproteinase 1, suggesting loss of wild type FGFR4 would adversely influence disease progression [46].